| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/14/2002 | CA2418904A1 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/14/2002 | CA2415469A1 Quinoline derivatives having vegf inhibiting activity |
| 02/13/2002 | EP1178986A2 Furanone derivatives as inhibitors of cathepsin s |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
| 02/13/2002 | EP1178969A1 Gastrin and cholecystokinin receptor ligands |
| 02/13/2002 | EP1178967A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178962A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178800A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 02/13/2002 | EP0861236B1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 02/13/2002 | EP0711768B1 Benzimidazole derivative |
| 02/13/2002 | EP0699069B1 Endothelin receptor antagonists |
| 02/13/2002 | CN1335843A Thiourea inhibitors of herpes viruses |
| 02/13/2002 | CN1335837A Imidazole compounds and medicinal use thereof |
| 02/13/2002 | CN1335835A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5HT1A receptor activity |
| 02/13/2002 | CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/13/2002 | CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent |
| 02/13/2002 | CN1335314A Process for producing 2-substituted benzo [b] thiazoles intermediate |
| 02/13/2002 | CN1335309A New eka-favone and its application in preparation of cosmetic and dermatology |
| 02/13/2002 | CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 02/13/2002 | CN1079096C Arylsulfonylimidazolone derivatives as antitumor agent |
| 02/12/2002 | US6346630 3-Arylbenzofuranones as stabilizers |
| 02/12/2002 | US6346627 Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers |
| 02/12/2002 | US6346625 Protein kinase inhibitors |
| 02/12/2002 | US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/12/2002 | US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/12/2002 | US6346540 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives |
| 02/12/2002 | US6346539 Treatment of skin conditions |
| 02/12/2002 | US6346533 Dissolving in solvent; low to high speed drying; high air pressure atomizing; reduced particle size; bioavailability |
| 02/12/2002 | US6346527 Guanidine derivatives |
| 02/12/2002 | US6346522 1-arylpyrazoles; systemic pesticides, insecticides, larvicides, miticides, antiprotozoa, and anthelmintic agents; agriculture, horticulture, animal husbandry, public health and veterinary medicine |
| 02/12/2002 | US6346520 Antitumor and anticarcinogenic agents; psoriasis |
| 02/12/2002 | CA2221190C Novel substituted taxanes and pharmaceutical compositions containing them |
| 02/12/2002 | CA2193939C Useful form of anhydrous paroxetine hydrochloride |
| 02/12/2002 | CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present |
| 02/12/2002 | CA2048139C N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 02/12/2002 | CA2024399C Compounds |
| 02/12/2002 | CA2018442C Antifungal 4-¬4-¬4-¬4-¬¬2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1,3-dioxolan-4-yl|methoxy|phenyl|-1piperazinyl|triazolones and imidazolones |
| 02/07/2002 | WO2002010159A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010157A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010156A1 Benzofuran derivatives and their use as antibacterial agents |
| 02/07/2002 | WO2002010150A1 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
| 02/07/2002 | WO2002010149A1 1,3-dioxolanes with antitussive activity |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 02/07/2002 | WO2002009648A2 Antimicrobial biaryl compounds |
| 02/07/2002 | WO2001081310A8 1-aroyl-piperidinyl benzamidines |
| 02/07/2002 | WO2001060806A3 Substituted arylpyrazines |
| 02/07/2002 | WO2000032578A8 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/07/2002 | US20020016345 Pyridine ketones useful as herbicides |
| 02/07/2002 | US20020016337 Heterocyclic analgesic compounds and methods of use thereof |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016324 Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them |
| 02/07/2002 | DE10036818A1 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten New N-triazolylmethyl piperazine derivatives as neurokinin receptor antagonists |
| 02/07/2002 | DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives |
| 02/07/2002 | CA2418121A1 Antimicrobial biaryl compounds |
| 02/07/2002 | CA2418071A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis |
| 02/07/2002 | CA2417650A1 Indazole derivatives as jnk inhibitors and compositions and methods related thereto |
| 02/07/2002 | CA2417277A1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta. |
| 02/07/2002 | CA2417204A1 Imidazolyl derivatives |
| 02/06/2002 | EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| 02/06/2002 | EP1177192A2 Antifungal ethers |
| 02/06/2002 | EP1177191A1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 02/06/2002 | EP1177190A2 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION |
| 02/06/2002 | EP1177188A1 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177181A1 Substituted bicyclic compounds |
| 02/06/2002 | EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof |
| 02/06/2002 | EP1177177A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/06/2002 | EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1177172A1 3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS |
| 02/06/2002 | EP1176982A1 Prucalopride oral solution |
| 02/06/2002 | EP1176959A1 Novel prolines as antimicrobial agents |
| 02/06/2002 | EP1176958A1 Novel catechols as antimicrobial agents |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP1176952A2 2r,4s-hydroxyitraconazole isomers |
| 02/06/2002 | EP0882024B1 Retroviral protease inhibiting compounds |
| 02/06/2002 | EP0861077B1 Hemoregulatory compounds |
| 02/06/2002 | EP0843551B1 Endothelin receptor antagonists |
| 02/06/2002 | EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/05/2002 | US6344570 Substituted urea derivatives as cell adhesion inhibitors |
| 02/05/2002 | US6344564 Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones |
| 02/05/2002 | US6344563 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/05/2002 | US6344464 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/05/2002 | US6344463 Skin disorders, acne |
| 02/05/2002 | US6344462 Heterocyclic compounds as bradykinin antagonists |
| 02/05/2002 | US6344460 Propynyl uracils |
| 02/05/2002 | US6344456 Piperazinone derivatives and their uses |
| 02/05/2002 | US6344453 Insecticidal heterocyclic compounds |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344320 Electrophoresis of nascent proteins |
| 02/05/2002 | CA2217513C Pharmaceutical agents for the treatment of alzheimer's disease |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |